col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


77 Results       Page 1

 [1] 
Wiley: Research and Practice in Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2023―May―18 Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies Jana van den Berg, Jasmin D. Haslbauer, Anna K. Stalder, Anna Romanens, Kirsten D. Mertz, Jan-Dirk Studt, et al. (+4)
2 [GO] 2023―Apr―26 VENOUS THROMBOEMBOLISM SECONDARY TO HOSPITALIZATION FOR COVID-19 DISEASE: PATIENT MANAGEMENT AND LONG-TERM OUTCOMES Walter Ageno, Emilia Antonucci, Daniela Poli, Eugenio Bucherini, Antonio Chistolini, Vittorio Fregoni, et al. (+12)
3 [GO] 2023―Mar―15 SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms Oscar Borsani, Virginia V. Ferretti, Ilaria C. Casetti, Daniele Vanni, Chiara Trotti, Daniela Pietra, et al. (+3)
4 [GO] 2023―Mar―08 Thrombosis and bleeding in COVID-19 patients requiring extracorporeal membrane oxygenation: A systematic review and meta-analysis Yu Jin, Yang Zhang, Jinping Liu, Zhou Zhou
5 [GO] 2023―Feb―15 COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic Hanny Al-Samkari
6 [GO] 2023―Feb―14 Endothelial cell activation, Weibel-Palade body secretion and enhanced angiogenesis in severe COVID-19 Ellie Karampini, Helen Fogarty, Stephanie Elliott, Hannah Morrin, Colm Bergin, Jamie M. O’Sullivan, et al. (+11)
7 [GO] 2023―Feb―08 Venous or Arterial Thrombosis in COVID-19 Cases in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Michael E. DeWitt, David M. Herrington, John W. Sanders
8 [GO] 2023―Feb―06 Convalescent Plasma Therapy for COVID-19 in Ambulatory vs Hospitalized Patients: Efficacy and Risk of Thromboembolism Pei Ye Li, Philip Yu, Allen Li, Faran Khalid, Marissa Liselle Laureano, Mark Andrew Crowther
9 [GO] 2023―Jan―30 SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, Xue-Yan Cui, Magnus Kringstad Olsen, Hege Karine Jacobsen, et al. (+12)
10 [GO] 2023―Jan―28 Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function Marina Rieder, Niklas Baldus, Daniela Stallmann, Maren Jeserich, Isabella Goller, Luisa Wirth, et al. (+10)
11 [GO] 2023―Jan―14 No changes in haemostasis after COVID-19-heterologous vaccination schedule: a sub analysis of the phase 2 CombiVacS study Nora V. Butta, Elena G. Arias-Salgado, Elena Monzón Manzano, Paula Acuña, María Teresa Álvarez Román, Antonio Buño-Soto, et al. (+11)
12 [GO] 2023―Jan―14 Sex Differences in D-Dimer and Critical Illness in COVID-19 Patients: A Systematic Review and Meta-analysis Olivia Saville, Malak Elbatarny, Yousra Tera, Yan Deng, Maha Othman
13 [GO] 2023―Jan―11 Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19 Quan Zhang, Zhan Ye, Paul McGowan, Christopher Jurief, Andrew Ly, Antonia Bignotti, et al. (+2)
14 [GO] 2023―Jan―10 Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients Philip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, Chee Wee Tan, Anoop Enjeti, Vivien Mun Yee Chen, et al. (+8)
15 [GO] 2023―Jan―07 Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study Arielle Mendel, Marvin J. Fritzler, Yvan St-Pierre, Joyce Rauch, Sasha Bernatsky, Évelyne Vinet
16 [GO] 2022―Nov―16 Pulmonary embolism-related mortality during the COVID -19 pandemic: Data from the United States Karlyn A. Martin, Katharine Harrington, Xiaoning Huang, Sadiya S. Khan
17 [GO] 2022―Nov―16 Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients Deepa J. Arachchillage, Christina Crossette-Thambiah, Namir Asmar, Saipriya Ramji, Mike Laffan
18 [GO] 2022―Oct―31 Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P. Martens, Valérie Spalart, et al. (+50)
19 [GO] 2022―Jul―21 Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19 Scott C. Woller, Scott M. Stevens, Joseph R. Bledsoe, Masarret Fazili, James F. Lloyd, Greg L. Snow, Benjamin D. Horne
20 [GO] 2022―Jun―17 No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease Jérémie Botton, Laura Semenzato, Julie Dupouy, Rosemary Dray-Spira, Alain Weill, Olivier Saint-Lary, Mahmoud Zureik
21 [GO] 2022―May―30 To escalate thromboprophylacic heparin intensity in COVID-19 or not? That is still the question Behnood Bikdeli
22 [GO] 2022―May―26 D-dimer testing in clinical practice in the era of COVID-19 Claire Auditeau, Lina Khider, Benjamin Planquette, Olivier Sanchez, David M. Smadja, Nicolas Gendron
23 [GO] 2022―May―18 Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean-Luc Reny, et al. (+13)
24 [GO] 2022―May―02 Platelet-leukocyte interactions in COVID-19: Contributions to hypercoagulability, inflammation, and disease severity Eugenio D. Hottz, Patrícia T. Bozza
25 [GO] 2022―Apr―20 Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in England Hannah Higgins, Nick Andrews, Julia Stowe, Gayatri Amirthalingam, Mary Ramsay, Gurpreet Bahra, et al. (+17)
26 [GO] 2022―Apr―15 Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Allison P. Wheeler
27 [GO] 2022―Apr―05 Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, et al. (+14)
28 [GO] 2022―Mar―21 MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Dudley Benjamin Christie, Sarah Orfanos, Lorenzo Anez-Bustillos, et al. (+26)
29 [GO] 2022―Feb―16 COVID-19 and venous thromboembolism: A narrative review Dana E. Angelini, Scott Kaatz, Rachel P. Rosovsky, Rebecca L. Zon, Shreejith Pillai, William E. Robertson, et al. (+3)
30 [GO] 2022―Feb―08 Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination William Deucher, Senthil Sukumar, Spero R. Cataland
31 [GO] 2022―Jan―25 The ongoing enigma of SARS-CoV-2 and platelet interaction Younes Zaid, Fadila Guessous
32 [GO] 2022―Jan―15 Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019 Tushar Sehgal, Mukul Aggarwal, Upendra Baitha, Gaurav Gupta, Bindu Prakash, Anu Gupta, et al. (+3)
33 [GO] 2022―Jan―15 Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia Kochawan Boonyawat, Pantep Angchaisuksiri
34 [GO] 2021―Dec―17 Randomized trials of therapeutic heparin for COVID-19: A meta-analysis Michelle Sholzberg, Bruno R. Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, et al. (+13)
35 [GO] 2021―Nov―21 Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies Noppacharn Uaprasert, Sasinipa Trithiphen, Autcharaporn Sukperm, Benjaporn Akkawat, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, et al. (+4)
36 [GO] 2021―Nov―03 The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep Johannes Thaler, Cihan Ay, Paul Knoebl
37 [GO] 2021―Oct―16 Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter
38 [GO] 2021―Oct―12 Prevalence of anti-platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais Phichchapha Noikongdee, Pornnapa Police, Tichayapa Phojanasenee, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, et al. (+3)
39 [GO] 2021―Sep―25 Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge Anne-Marije Hulshof, Dionne C. W. Braeken, Chahinda Ghossein-Doha, Susanne van Santen, Jan-Willem E. M. Sels, Gerhardus J. A. J. M. Kuiper, et al. (+5)
40 [GO] 2021―Sep―18 Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, et al. (+4)
41 [GO] 2021―Sep―13 Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis Golzar Mobayen, Amrita Dhutia, Candice Clarke, Maria Prendecki, Stephen McAdoo, Renos Keniyopoullos, et al. (+4)
42 [GO] 2021―Aug―25 Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report Bader Al Rawahi, Hashem BaTaher, Zoheb Jaffer, Aya Al-Balushi, Asma Al-Mazrouqi, Noof Al-Balushi
43 [GO] 2021―Jun―28 Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin
44 [GO] 2021―May―19 Comparison of the coagulopathies associated with COVID-19 and sepsis Robert A. Campbell, Yohei Hisada, Frederik Denorme, Steven P. Grover, Emma G. Bouck, Elizabeth A. Middleton, et al. (+3)
45 [GO] 2021―May―08 Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study Lachelle D. Weeks, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell
46 [GO] 2021―Mar―08 Caging the dragon: Research approach to COVID-19-related thrombosis Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. Gorp, Nicole P. Juffermans, Frederikus A. Klok, et al. (+2)
47 [GO] 2021―Feb―24 Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19 Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, et al. (+6)
48 [GO] 2021―Feb―18 Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients MAM Stals, MJJH Grootenboers, C van Guldener, FHJ Kaptein, SJE Braken, Q Chen, et al. (+10)
49 [GO] 2021―Jan―15 Vascular thromboembolic events following COVID-19 hospital discharge: incidence and risk factors Harish Eswaran, Jamie A. Jarmul, Amy W. Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
50 [GO] 2021―Jan―05 COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy Alice Assinger
51 [GO] 2020―Dec―07 Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality Fien A. Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann-Sofie Rudberg, Maria Magnusson, et al. (+3)
52 [GO] 2020―Nov―10 eThrombosis: A new risk factor for venous thromboembolism in the pandemic era Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita
53 [GO] 2020―Oct―21 Harmonizing Hypercoagulable Heterogeneity: Baseline VTE Risk in COVID-19 George Goshua, Alfred Ian Lee
54 [GO] 2020―Sep―28 COVID-19 pandemic perspectives: A scientific silver lining? Dre'Von A. Dobson, Alisa S. Wolberg
55 [GO] 2020―Sep―25 Thrombo-inflammation response to Tocilizumab in COVID-19 Mansour Gergi, Mary Cushman, Benjamin Littenberg, Ralph C. Budd
56 [GO] 2020―Sep―25 Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay
57 [GO] 2020―Sep―19 Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients Nithita Nanthatanti, Sithakom Phusanti, Pichika Chantrathammachart, Kanin Thammavaranucupt, Pantep Angchaisuksiri, Somnuek Sungkanuparph
58 [GO] 2020―Jul―14 The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Jori E. May, Rance C. Siniard, Marisa Marques
59 [GO] 2020―Jul―11 Thrombosis and coagulopathy in COVID-19: An illustrated review Marcel Levi, Beverley J. Hunt
60 [GO] 2020―Jul―09 Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
61 [GO] 2020―Jul―09 Anticoagulation Practice Patterns in COVID-19: A Global Survey Rachel P. Rosovsky, Kristen M Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, et al. (+8)
62 [GO] 2020―Jun―25 Staying updated on COVID-19: social media to amplify science in thrombosis and haemostasis Mike Makris
63 [GO] 2020―Jun―14 The underrecognized prothrombotic vascular disease of COVID-19 Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos
64 [GO] 2020―Jun―08 Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis Mary Cushman
65 [GO] 2020―May―29 Anticoagulation, Immortality, and Observations of COVID-19 Jason H. Maley, Camille R. Petri, Laura N. Brenner, Raghu R. Chivukula, Tiara F. Calhoun, Vladimir Vinarsky, C. Corey Hardin
66 [GO] 2020―May―29 Potential Role of Platelets in COVID-19: Implications for Thrombosis Milka Koupenova
67 [GO] 2020―May―21 STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhnuwala, Robert C. McIntyre, Peter K Moore, et al. (+5)
68 [GO] 2020―May―20 Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 Adult Respiratory Distress Syndrome Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
69 [GO] 2020―May―20 Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a University Hospital Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay
70 [GO] 2020―May―14 Venous Thromboembolism in Critically Ill Patients with Covid-19: Results of a Screening Study for Deep Vein Thrombosis Alban Longchamp, Justine Longchamp, Sara Manzocchi-Besson, Livia Whiting, Claude Haller, Séverin Jeanneret, et al. (+16)
71 [GO] 2020―May―11 A Proposal for Staging COVID-19 Coagulopathy Jecko Thachil, Mary Cushman, Alok Srivastava
72 [GO] 2020―May―06 Thrombosis and Thromboembolism Related to COVID-19 A clarion call for obtaining solid estimates from large-scale multicenter data Stefano Barco, Stavros V Konstantinides
73 [GO] 2020―May―04 COVID-19 Hypothesis: Activated Protein C for Therapy of Virus-induced Pathologic Thromboinflammation John H. Griffin, Patrick Lyden
74 [GO] 2020―Apr―28 Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, John Burke, et al. (+7)
75 [GO] 2020―Apr―28 Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019 Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos
76 [GO] 2020―Apr―21 COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Suzanne C Cannegieter, Frederikus A Klok
77 [GO] 2020―Apr―18 The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19 JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, et al. (+4)
 [1] 

77 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.009 sec